Skip to main content
. 2011 Jul 9;4(2):358–362. doi: 10.1159/000330239

Fig. 2.

Fig. 2

a Tumor showing a mixture of carcinomatous and sarcomatous components (HE, ×100). b Tumor cells in the hepatoid areas immunoreactive for AFP (AFP, ×400).